Rocket Pharmaceuticals Inc.
RCKT | NASDAQ
$3.27
-$0.10 (-2.97%)
At close: Sep 21, 2026, 4:00 PM ET
$3.27
$0 (+0.03%)
Pre-market:
Sep 22, 2026, 8:24 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 2.15M | n/a | n/a | n/a | n/a | n/a | n/a | 2.34M | 2.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -2.15M | n/a | n/a | n/a | n/a | n/a | n/a | -2.34M | -2.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -46.92M | -48.51M | -43.96M | -52.25M | -71.15M | -64.39M | -62.69M | -69.42M | -73.71M | -67.38M | -63.28M | -65.43M | -68.76M | -62.19M | -69.08M | -58.49M | -54.21M | -42.56M | -44.33M | -49.65M | -34.05M | -39.22M |
Interest Income | n/a | 1.49M | 6.23M | 2.39M | 2.7M | 3.53M | 2.84M | 3.18M | 4.54M | 5.79M | 4.09M | 4M | 3.52M | 4.33M | 2.33M | 1.35M | 669K | 623K | 849K | 806K | 501K | 272K |
Pretax Income | 131.84M | -47.59M | -42.54M | -50.33M | -68.92M | -61.33M | -60.33M | -66.72M | -69.65M | -62.05M | -59.66M | -61.9M | -65.7M | -58.34M | -66.72M | -57.76M | -54.4M | -42.98M | -44.25M | -50.12M | -34.53M | -40.18M |
Net Income | 123.21M | -47.59M | -42.54M | -50.33M | -68.92M | -61.33M | -60.33M | -66.72M | -69.65M | -62.05M | -59.66M | -61.9M | -65.7M | -58.34M | -66.72M | -57.76M | -54.4M | -42.98M | -44.25M | -50.12M | -34.53M | -40.18M |
Selling & General & Admin | 17.43M | 17.06M | 14.68M | 18.35M | 25.02M | 28.45M | 25.34M | 27.11M | 26.58M | 21.36M | 21.54M | 18.59M | 17.37M | 15.82M | 19.05M | 15.11M | 12.85M | 11.77M | 12.17M | 10.03M | 9.52M | 10.91M |
Research & Development | 29.5M | 31.45M | 29.35M | 34.07M | 42.66M | 35.94M | 37.36M | 42.32M | 44.79M | 43.76M | 41.74M | 46.84M | 51.38M | 46.37M | 50.04M | 43.38M | 41.36M | 30.79M | 32.16M | 39.62M | 24.53M | 28.31M |
Other Expenses | n/a | -2.15M | -68K | -172K | 3.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 46.92M | 46.37M | 43.96M | 52.25M | 71.15M | 64.39M | 62.69M | 69.42M | 71.37M | 65.12M | 63.28M | 65.43M | 68.76M | 62.19M | 69.08M | 58.49M | 54.21M | 42.56M | 44.33M | 49.65M | 34.05M | 39.22M |
Interest Expense | 473K | 473K | 3.31M | 473K | 473K | 472K | 473K | 471K | 471K | 471K | 470K | 469K | 468K | 468K | 467K | 621K | 861K | 1.04M | 1.26M | 1.28M | 978K | 1.73M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -786K | -787K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 46.92M | 48.51M | 43.96M | 52.25M | 71.15M | 64.39M | 62.69M | 69.42M | 73.71M | 67.38M | 63.28M | 65.43M | 68.76M | 62.19M | 69.08M | 58.49M | 54.21M | 42.56M | 44.33M | 49.65M | 34.05M | 39.22M |
Income Tax Expense | 8.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 112.84M | 112.13M | 111.12M | 111.57M | 111.02M | 110.09M | 97.53M | 94.16M | 93.75M | 93.55M | 93.34M | 82.64M | 80.47M | 79.45M | 72.89M | 66.22M | 65.48M | 64.51M | 64.47M | 63.83M | 63.06M | 61.57M |
Shares Outstanding (Diluted) | 114.51M | 112.13M | 111.12M | 111.57M | 111.02M | 110.09M | 97.53M | 94.16M | 93.75M | 93.55M | 93.34M | 82.64M | 80.47M | 79.45M | 72.89M | 66.22M | 65.48M | 64.51M | 64.47M | 63.83M | 63.06M | 61.57M |
EPS (Basic) | 1.09 | -0.42 | -0.38 | -0.45 | -0.62 | -0.56 | -0.62 | -0.71 | -0.74 | -0.66 | -0.64 | -0.75 | -0.82 | -0.69 | -0.88 | -0.86 | -0.83 | -0.67 | -0.69 | -0.79 | -0.55 | -0.65 |
EPS (Diluted) | 1.08 | -0.42 | -0.38 | -0.45 | -0.62 | -0.56 | -0.62 | -0.71 | -0.74 | -0.66 | -0.64 | -0.75 | -0.82 | -0.69 | -0.88 | -0.86 | -0.83 | -0.67 | -0.69 | -0.79 | -0.55 | -0.65 |
EBITDA | 136.56M | -44.98M | -37.01M | -46.62M | -65.87M | -57.87M | -57.49M | -63.86M | -66.84M | -59.33M | -57.26M | -59.67M | -63.5M | -56.19M | -63.95M | -55.52M | -51.98M | -40.64M | -39.8M | -48.03M | -32.84M | -37.14M |
EBIT | 132.31M | -47.12M | -39.23M | -49.86M | -68.45M | -60.86M | -59.85M | -66.25M | -69.18M | -61.58M | -59.19M | -61.43M | -65.23M | -57.87M | -67.34M | -57.14M | -53.54M | -41.94M | -42.98M | -48.84M | -33.55M | -37.81M |
Depreciation & Amortization | 4.25M | 2.15M | 2.22M | 3.24M | 2.58M | 2.99M | 2.36M | 2.39M | 2.34M | 2.25M | 1.94M | 1.76M | 1.73M | 1.67M | 3.38M | 1.62M | 1.57M | 1.3M | 3.19M | 808K | 706K | 674K |
Add to Watchlist
Select watchlists to add or remove RCKT